Outcomes of de‐prescribing proton pump inhibitors during acute admissions in a general medical unit: a pilot study

Abstract

AbstractThe study describes the feasibility and short‐to‐medium‐term efficacy of an evidence‐based proton pump inhibitor (PPI) de‐prescribing initiative undertaken as part of routine clinical care during acute admissions in a general medical unit. Of the 44 (median (IQR) age 75.5 (13.75) years; females 25 (57%)) who participated in the study, de‐prescription was maintained in 29 (66%) and 27 (61%) patients at 12 and 26 weeks respectively.